Cohance Lifesciences Ltd. logo

Cohance Lifesciences Ltd. share price

NSE: COHANCE · Healthcare

₹457.60 -0.22%

Closing price data, updated 17 Nov 2026. 52-week range: -34.4% from high, +71.6% above low.

Price₹457.60
Market cap₹17,508 Cr
P/E369.6
P/B4.48
ROE4.7%
ROCE4.8%
Debt / equity0.10
Dividend yield0.00%
EPS₹1.24
Book value₹102.25
Operating margin11.2%
Dipscan score33 / 100
Open full analysis, charts & financials →

Share: WhatsAppX / TwitterTelegram

Cohance Lifesciences Ltd. shareholding pattern

As of Sep 2026: Promoters 57.48%, FIIs 7.71%, DIIs 18.86%, Government 0.00%, Public 7.50%, Others 8.46%.

HolderSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025
Promoters57.48%57.49%57.49%57.49%57.49%66.41%
FIIs7.71%6.50%5.59%6.02%6.51%7.23%
DIIs18.86%20.09%21.79%21.57%20.82%11.40%
Government0.00%0.01%0.01%0.01%0.01%0.01%
Public7.50%7.71%7.04%6.76%6.42%6.40%
Others8.46%8.21%8.08%8.16%8.75%8.55%
No. of Shareholders93,84699,14985,23081,87775,28480,910

As filed by the company with the exchanges.

Returns

1 day1 week1 month3 months6 months1 year
-0.22%+5.55%+2.69%+3.02%+2.79%-33.78%

Growth

Sales growth, 3 years+18.3%
Sales growth, 5 years–
Profit growth, 3 years-24.2%
Profit growth, 5 years–
Latest quarter sales vs last year-14.2%
Latest quarter profit vs last year-79.5%

Strengths and weaknesses

Weaknesses

Peers in Healthcare

CompanyPriceMarket capP/EROE1 year
Sun Pharmaceutical Industries ₹1,867.50₹4,48,076 Cr40.914.7%+8.8%
Divi's Laboratories Ltd.₹11,080.00₹2,94,139 Cr87.516.2%+69.4%
Torrent Pharmaceuticals Ltd.₹4,691.20₹1,78,438 Cr84.027.1%+22.6%
Apollo Hospitals Enterprise Lt₹8,771.00₹1,26,114 Cr56.221.9%+16.9%
Laurus Labs Ltd.₹2,220.00₹1,19,949 Cr89.518.2%+125.2%
Zydus Lifesciences Ltd.₹1,192.00₹1,18,902 Cr28.419.7%+27.0%
Dr. Reddy's Laboratories Ltd.₹1,377.90₹1,14,778 Cr41.012.1%+13.7%
Cipla Ltd.₹1,394.50₹1,12,658 Cr38.911.8%-8.0%

Frequently asked questions

What is the share price of Cohance Lifesciences Ltd.?

Cohance Lifesciences Ltd. (COHANCE) last closed at ₹457.60 (-0.22% on the day).

What is the market cap of Cohance Lifesciences Ltd.?

About ₹17,508 Cr.

What is the P/E ratio of Cohance Lifesciences Ltd.?

The price-to-earnings ratio is 369.6, and return on equity is 4.7%.

Figures are calculated from company results and exchange prices and are for information only.